Desmoplastic Reaction Associates with Prognosis and Adjuvant Chemotherapy Response in Colorectal Cancer: A Multicenter Retrospective Study

被引:3
|
作者
Hu, Qingru [1 ,2 ,3 ]
Wang, Yiting [4 ]
Yao, Su [5 ]
Mao, Yun [6 ]
Liu, Liu [6 ]
Li, Zhenhui [2 ,7 ,8 ]
Chen, Yonghe [9 ]
Zhang, Shenyan [4 ]
Li, Qian [10 ]
Zhao, Yingnan
Fan, Xinjuan
Cui, Yanfen [2 ,7 ]
Zhao, Ke [22 ,2 ,11 ]
Liu, Zaiyi [1 ,2 ,3 ]
机构
[1] Southern Med Univ, Guangdong Prov Peoples Hosp, Guangdong Acad Med Sci, Dept Radiol, Guangzhou, Peoples R China
[2] Guangdong Prov Key Lab Artificial Intelligence Me, Guangzhou, Peoples R China
[3] Southern Med Univ, Sch Clin Med 2, Guangzhou, Peoples R China
[4] Sun Yat Sen Univ, Affiliated Hosp 6, Dept Pathol, Guangzhou, Peoples R China
[5] Southern Med Univ, Guangdong Prov Peoples Hosp, Guangdong Acad Med Sci, Dept Pathol, Guangzhou, Peoples R China
[6] Chongqing Med Univ, Affiliated Hosp 1, Dept Radiol, Chongqing, Peoples R China
[7] Guangdong Prov Peoples Hosp, Guangdong Acad Med Sci, Guangdong Cardiovasc Inst, Guangzhou, Peoples R China
[8] Kunming Med Univ, Yunnan Canc Hosp, Affiliated Hosp 3, Yunnan Canc Ctr,Dept Radiol, Kunming, Peoples R China
[9] Sun Yat Sen Univ, Affiliated Hosp 6, Dept Gastrointestinal Surg, Guangzhou, Peoples R China
[10] South China Univ Technol, Sch Med, Guangzhou, Peoples R China
[11] Guangdong Prov Peoples Hosp, Guangzhou 510080, Guangdong, Peoples R China
来源
CANCER RESEARCH COMMUNICATIONS | 2023年 / 3卷 / 06期
基金
美国国家科学基金会; 中国博士后科学基金; 中国国家自然科学基金;
关键词
COLON-CANCER; STROMA; CATEGORIZATION; SUBTYPES;
D O I
10.1158/2767-9764.CRC-23-0073
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Desmoplastic reaction (DR) is one of many tumor-host interactions and is associated with the overall survival (OS) of patients with colorectal cancer. However, the clinical significance of DR requires further study in large multicenter cohorts and its predictive value in adjuvant chemotherapy (ACT) response remains unclear. Here, a total of 2,225 patients with colorectal cancer from five independent institutions were divided into primary (N = 1,012 from two centers) and validation (N = 1,213 from three centers) cohorts. DR was classified as immature, middle, or mature depending on the presence of myxoid stroma and hyalinized collagen bundles at the invasive front of the primary tumor. OS among different subgroups were compared, and the correlations of DR type with tumor-infiltrating lymphocytes (TILs) within stroma, tumor stroma ratio (TSR), and Stroma AReactive Invasion Front Areas (SARIFA) were also analyzed. In the primary cohort, patients with mature DR had the highest 5-year survival rate. These findings were confirmed in validation cohort. In addition, for stage II colorectal cancer, patients classified as non-mature DR would benefit from ACT compared with surgery alone. Furthermore, immature and middle DR were more associated with high TSR, less distribution of TILs within stroma and positive SARIFA compared with mature. Taken together, these data suggest that DR is a robust-independent prognostic factor for patients with colorectal cancer. For patients with stage II colorectal cancer, non-mature DR could be a potential marker for recognizing high-risk patients who may benefit from ACT.Significance: DR has the potential to identify patients with high-risk colorectal cancer and predict the efficacy of adjuvant chemotherapy in patients with stage II colorectal cancer. Our findings support reporting DR types as additional pathologic parameters in clinical practice for more precise risk stratification.
引用
收藏
页码:1057 / 1066
页数:10
相关论文
共 50 条
  • [1] The Glasgow Microenvironment Score associates with prognosis and adjuvant chemotherapy response in colorectal cancer
    Alexander, Peter G.
    Roseweir, Antonia K.
    Pennel, Kathryn A. F.
    van Wyk, Hester C.
    Powell, Arfon G. M. T.
    McMillan, Donald C.
    Horgan, Paul G.
    Kelly, Caroline
    Hay, Jennifer
    Sansom, Owen
    Harkin, Andrea
    Roxburgh, Campbell S. D.
    Graham, Janet
    Church, David N.
    Tomlinson, Ian
    Saunders, Mark
    Iveson, Tim J.
    Edwards, Joanne
    Park, James H.
    BRITISH JOURNAL OF CANCER, 2021, 124 (04) : 786 - 796
  • [2] The Glasgow Microenvironment Score associates with prognosis and adjuvant chemotherapy response in colorectal cancer
    Peter G. Alexander
    Antonia K. Roseweir
    Kathryn A. F. Pennel
    Hester C. van Wyk
    Arfon G. M. T. Powell
    Donald C. McMillan
    Paul G. Horgan
    Caroline Kelly
    Jennifer Hay
    Owen Sansom
    Andrea Harkin
    Campbell S. D. Roxburgh
    Janet Graham
    David N. Church
    Ian Tomlinson
    Mark Saunders
    Tim J. Iveson
    Joanne Edwards
    James H. Park
    British Journal of Cancer, 2021, 124 : 786 - 796
  • [3] Desmoplastic Reaction, Immune Cell Response, and Prognosis in Colorectal Cancer
    Akimoto, Naohiko
    Vayrynen, Juha P.
    Zhao, Melissa
    Ugai, Tomotaka
    Fujiyoshi, Kenji
    Borowsky, Jennifer
    Zhong, Rong
    Haruki, Koichiro
    Arima, Kota
    Lau, Mai Chan
    Kishikawa, Junko
    Twombly, Tyler S.
    Takashima, Yasutoshi
    Song, Mingyang
    Zhang, Xuehong
    Wu, Kana
    Chan, Andrew T.
    Meyerhardt, Jeffrey A.
    Giannakis, Marios
    Nowak, Jonathan A.
    Ogino, Shuji
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [4] Effectiveness of adjuvant chemotherapy in patients with Stage II colorectal cancer: A multicenter retrospective study
    Jalaeikhoo, Hasan
    Zokaasadi, Mohammad
    Khajeh-Mehrizi, Ahmad
    Rajaeinejad, Mohsen
    Mousavi, Seied Asadollah
    Vaezi, Mohammad
    Fumani, Hosein Kmranzadeh
    Keyhani, Manoutchehr
    Alimoghaddam, Kamran
    Ghavamzadeh, Ardeshir
    JOURNAL OF RESEARCH IN MEDICAL SCIENCES, 2019, 24
  • [5] Significance of Adjuvant Chemotherapy for Obstructive Colorectal Cancer After Stent Placement: A Multicenter Retrospective Study
    Matsuda, Akihisa
    Yamada, Takeshi
    Takahashi, Goro
    Matsumoto, Satoshi
    Yokoyama, Yasuyuki
    Sonoda, Hiromichi
    Uehara, Kay
    Shinji, Seiichi
    Sekiguchi, Kumiko
    Kanaka, Shintaro
    Yoshida, Hiroshi
    ANTICANCER RESEARCH, 2024, 44 (06) : 2737 - 2745
  • [6] A Retrospective Multicenter Study of the Clinicopathological Characteristics and Prognosis of Young Adult Patients with Colorectal Cancer: Effects of Chemotherapy on Prognosis
    Son, Il Tae
    Kang, Jae Hyun
    Kim, Byung Chun
    Park, Jun Ho
    Kim, Jong Wan
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (11)
  • [7] Desmoplastic reaction in biopsy specimens of early colorectal cancer: A Japanese prospective multicenter study
    Kimura, Ryusuke
    Fujimori, Takahiro
    Ichikawa, Kazuhito
    Ajioka, Yoichi
    Ueno, Hideki
    Ohkura, Yasuo
    Kashida, Hiroshi
    Togashi, Kazutomo
    Yao, Takashi
    Wada, Ryo
    Watanabe, Toshiaki
    Ochiai, Atsushi
    Sugai, Tamotsu
    Sugihara, Kenichi
    Igarashi, Yoshinori
    PATHOLOGY INTERNATIONAL, 2012, 62 (08) : 525 - 531
  • [8] A Multicenter Study of the Prognostic Value of Desmoplastic Reaction Categorization in Stage II Colorectal Cancer
    Ueno, Hideki
    Kanemitsu, Yukihide
    Sekine, Shigeki
    Ishiguro, Megumi
    Ito, Eisaku
    Hashiguchi, Yojiro
    Kondo, Fukuo
    Shimazaki, Hideyuki
    Kajiwara, Yoshiki
    Okamoto, Koichi
    Mochizuki, Satsuki
    Tsujimoto, Hironori
    Shinto, Eiji
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2019, 43 (08) : 1015 - 1022
  • [9] Colorectal Cancer With Methylator Phenotype. Clinical Characterisitics, Prognosis and Response to Adjuvant Chemotherapy
    Murcia, Oscar
    Rodriguez-Soler, Maria
    Juarez-Quesada, Miriam
    Guarinos, Carla
    Hernandez-Illan, Eva
    Andreu, Montserrat
    Castells, Antoni
    Llor, Xavier
    Carracedo, Angel
    Jover, Rodrigo
    GASTROENTEROLOGY, 2015, 148 (04) : S570 - S571
  • [10] Impact of response to preoperative chemotherapy on the outcome of pulmonary metastasectomy for colorectal cancer: Results of a retrospective multicenter study
    Okumura, T.
    Boku, N.
    Hishida, T.
    Ohde, Y.
    Sakao, Y.
    Yoshiya, K.
    Higashiyama, M.
    Kameyama, K.
    Adachi, H.
    Shiomi, K.
    Kanzaki, M.
    Yoshimura, M.
    Matsuura, M.
    Hata, Y.
    Chen, F.
    Yoshida, K.
    Sasaki, H.
    Hyodo, I.
    Mori, K.
    Kondo, H.
    ANNALS OF ONCOLOGY, 2018, 29 : 172 - 172